RADNOR, PA–(NewMediaWire)–December 28, 2024– The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) advises investors that a securities class action has been filed against Applied Therapeutics (NASDAQ: ) Inc. (Applied Therapeutics) (NASDAQ: APLT ) on behalf of those who purchased or otherwise acquired securities of Applied Therapeutics between and including January 3, 2024 and December 2, 2024 (the Class Period). The deadline for the chief prosecutor is February 18, 2025.
CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:
If you have suffered losses from Applied Therapeutics, you can CLICK HERE or copy and paste the following link into your browser: https://www.ktmc.com/new-cases/applied-therapeutics-inc?utm_source=PR&utm_medium=link&utm_campaign=aplt&mktm= r
You may also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or emailing info@ktmc.com.
ALLEGED MISCONDUCT OF THE ACCUSED:
The complaint alleges that during the Lecture Period, the defendants made false and/or misleading statements and/or failed to disclose that Applied Therapeutics did not follow trial protocols and good clinical practices for its drug candidate, gorestat, which in turn created an extremely serious risk that will the FDA reject trial data in the context of a new drug application.
PROCEDURE OF THE CHIEF PROSECUTOR:
Investors in Applied Therapeutics may, no later than February 18, 2025, seek to be appointed as the lead class plaintiff representative through Kessler Topaz Meltzer & Check, LLP or other counsel, or they may choose to do nothing and remain an absent class member. The lead plaintiff is the representative party that acts on behalf of all class members in the conduct of the litigation. The lead plaintiff is usually an investor or a small group of investors who have the greatest financial interest and who are also appropriate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and those attorneys, if approved by the court, are lead or class counsel. Deciding whether or not to be the lead claimant does not affect your ability to participate in the recovery.
Kessler Topaz Meltzer & Check, LLP encourages Applied Therapeutics investors who have suffered significant losses to contact the company directly for more information.
CLICK HERE TO APPLY FOR A CASE OR GO TO: https://www.ktmc.com/new-cases/applied-therapeutics-inc?utm_source=PR&utm_medium=link&utm_campaign=aplt&mktm=r
ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP litigates class actions in state and federal courts nationwide and around the world. The company has built a global reputation for excellence and has recovered billions of dollars from victims of fraud and other corporate wrongdoing. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by companies and fiduciaries. The appeal in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP, visit www.ktmc.com.
CONTACT:
Kessler Topaz Meltzer & Check, LLP
Jonathan Naji, Esq.
(484) 270-1453
280 King of Prussia Road
Radnor, PA 19087
info@ktmc.com
May be considered solicitor advertising in certain jurisdictions. Past results do not guarantee future results.
See the original release at www.newmediawire.com
Copyright 2024 JCN Newswire. All rights reserved.
